NeuBase Therapeutics, ABVC BioPharma, Stoke Therapeutics among healthcare movers

seekingalpha03-26

Gainers: Stoke Therapeutics STOK +79%. Mesoblast ADR MESO +29%. ABVC BioPharma (ABVC) +31%. Praxis Precision Medicines PRAX +25%. Check-Cap CHEK +23%. Losers: NeuBase Therapeutics (NBSE) -54%. Ampio ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2422616722?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-03-26 22:00","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2422616722","market":"sg","top_or_hot":-1,"title":"NeuBase Therapeutics, ABVC BioPharma, Stoke Therapeutics among healthcare movers","media":"seekingalpha","content":"<div>\n<p>Gainers: Stoke Therapeutics STOK +79%. Mesoblast ADR MESO +29%. ABVC BioPharma (ABVC) +31%. Praxis Precision Medicines PRAX +25%. Check-Cap CHEK +23%.  Losers: NeuBase Therapeutics (NBSE) -54%. Ampio ...</p>\n\n<a href=\"https://seekingalpha.com/news/4083716-neubase-therapeutics-abvc-biopharma-stoke-therapeutics-among-healthcare-movers\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NeuBase Therapeutics, ABVC BioPharma, Stoke Therapeutics among healthcare movers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNeuBase Therapeutics, ABVC BioPharma, Stoke Therapeutics among healthcare movers\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-26 22:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4083716-neubase-therapeutics-abvc-biopharma-stoke-therapeutics-among-healthcare-movers><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Gainers: Stoke Therapeutics STOK +79%. Mesoblast ADR MESO +29%. ABVC BioPharma (ABVC) +31%. Praxis Precision Medicines PRAX +25%. Check-Cap CHEK +23%.  Losers: NeuBase Therapeutics (NBSE) -54%. Ampio ...</p>\n\n<a href=\"https://seekingalpha.com/news/4083716-neubase-therapeutics-abvc-biopharma-stoke-therapeutics-among-healthcare-movers\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SDS","symbol_name":"两倍做空标普500ETF","start_time":0,"source_url":"https://seekingalpha.com/news/4083716-neubase-therapeutics-abvc-biopharma-stoke-therapeutics-among-healthcare-movers","article_id":"2422616722","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2422616722","pubTimestamp":1711461612,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Gainers: Stoke Therapeutics STOK +79%. Mesoblast ADR MESO +29%. ABVC BioPharma  +31%. Praxis Precision Medicines PRAX +25%. Check-Cap CHEK +23%.  Losers: NeuBase Therapeutics  -54%. Ampio Pharmaceuticals AMPE -51%. Tivic Health Systems TIVC -12%. Bluebird bio BLUE -13%. eFFECTOR Therapeutics EFTR -15%.  S&P 500 Health Care Sector +0.2% to 1697.44. Health Care Equipment & Services +0.34% to 1979.48. Pharmaceuticals, Biotechnology & Life Science which contributes 58% to index is +0.05% to 1385.07.  More on Health Care Select Sector SPDR  XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Johnson & Johnson, Boston Scientific least shorted stocks in S&P 500 healthcare sector for Feb-end Waters, Moderna most shorted stocks in S&P 500 health sector till Jan-end Seeking Alpha’s Quant Rating on Health Care Select Sector SPDR","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"SDS":"两倍做空标普500ETF","ABVC":"ABVC BioPharma, Inc.","BK4559":"巴菲特持仓","BK4550":"红杉资本持仓","BK4588":"碎股","UPRO":"三倍做多标普500ETF","SH":"标普500反向ETF","OEX":"标普100",".SPX":"S&P 500 Index","BK4581":"高盛持仓","IVV":"标普500指数ETF","BK4504":"桥水持仓","SSO":"两倍做多标普500ETF","OEF":"标普100指数ETF-iShares","SPXU":"三倍做空标普500ETF","SPY":"标普500ETF","LENZ":"Therapeutics","BK4585":"ETF&股票定投概念","NBSE":"NeuBase Therapeutics Inc.","BK4534":"瑞士信贷持仓","BK4139":"生物科技"},"translate_title":"NeuBase Therapeutics、ABVC BioPharma、Stoke Therapeutics在医疗保健行业中脱颖而出","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABVC":1,"NBSE":1,"LENZ":1,"SPY":0.9,"UPRO":0.6,".SPX":0.6,"SSO":0.6,"SPXU":0.6,"SH":0.6,"SDS":0.6,"OEX":0.6,"OEF":0.6,"IVV":0.6,"ESmain":0.6},"content_text":"Gainers: Stoke Therapeutics STOK +79%. Mesoblast ADR MESO +29%. ABVC BioPharma (ABVC) +31%. Praxis Precision Medicines PRAX +25%. Check-Cap CHEK +23%.  Losers: NeuBase Therapeutics (NBSE) -54%. Ampio Pharmaceuticals AMPE -51%. Tivic Health Systems TIVC -12%. Bluebird bio BLUE -13%. eFFECTOR Therapeutics EFTR -15%.  S&P 500 Health Care Sector +0.2% to 1697.44. Health Care Equipment & Services +0.34% to 1979.48. Pharmaceuticals, Biotechnology & Life Science which contributes 58% to index is +0.05% to 1385.07.  More on Health Care Select Sector SPDR  XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Johnson & Johnson, Boston Scientific least shorted stocks in S&P 500 healthcare sector for Feb-end Waters, Moderna most shorted stocks in S&P 500 health sector till Jan-end Seeking Alpha’s Quant Rating on Health Care Select Sector SPDR","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2422616722"}